The conflict of interest rules on publicly funded research

What the rule actually requires, in order

The subpart states its own purpose in one sentence: to promote objectivity in research by establishing standards that provide a reasonable expectation that the design, conduct and reporting of research funded under Public Health Service grants or cooperative agreements will be free from bias resulting from investigator financial conflicts of interest.

The machinery that follows runs in five steps. Investigators disclose their significant financial interests to their institution. The institution decides whether each interest is related to the funded research, and if so whether it is a financial conflict of interest. Where one exists, the institution develops and implements a written management plan before spending any of the award. It reports the conflict to the funding component. And for certain conflicts held by senior or key personnel, it makes defined information publicly accessible.

The duty falls on the institution, and it falls before the money moves. Prior to the institution's expenditure of any funds under a project, its designated officials must review all investigator disclosures, determine whether any relate to the funded research, determine whether a conflict exists, and if so develop and implement a management plan specifying the actions taken and to be taken.

Two words in the definitions carry most of the weight. A financial conflict of interest means a significant financial interest that could directly and significantly affect the design, conduct, or reporting of the funded research. Manage means taking action to address that conflict, which can include reducing or eliminating it, to ensure to the extent possible that the design, conduct and reporting of research will be free from bias. Neither definition asks whether bias actually occurred.

Five thousand dollars, aggregated, with two important edge cases

A significant financial interest is defined by reference to the investigator, their spouse and their dependent children, and only where the interest reasonably appears to be related to the investigator's institutional responsibilities.

For a publicly traded entity, the threshold is the aggregate of two things: any remuneration received from the entity in the twelve months preceding the disclosure, and the value of any equity interest in the entity as of the date of disclosure. If those together exceed five thousand dollars, the interest is significant. Remuneration is defined to include salary and any payment for services not otherwise identified as salary, and the rule names consulting fees, honoraria and paid authorship as examples. Equity interest includes stock, stock options or other ownership interest.

For a non-publicly traded entity the arithmetic changes. Remuneration above five thousand dollars in the preceding twelve months makes the interest significant — but so does holding any equity interest at all, at any value. A single share of a private company is a significant financial interest under this rule.

Intellectual property is treated on a trigger rather than a threshold. Intellectual property rights and interests, such as patents and copyrights, become a significant financial interest upon receipt of income related to those rights. Holding the patent is not the trigger; being paid for it is.

Travel is disclosed separately and without a stated dollar figure, precisely because the figure is often unavailable. Investigators must disclose reimbursed or sponsored travel related to their institutional responsibilities — travel paid on their behalf rather than reimbursed to them, so the exact value may not be readily known. The disclosure must include at a minimum the purpose of the trip, the identity of the sponsor or organiser, the destination and the duration. Travel reimbursed or sponsored by a government agency, an institution of higher education, an academic teaching hospital, a medical centre or an affiliated research institute is excluded.

What the rule expressly does not count

The exclusions are listed in the definition itself, and they explain why an investigator's disclosure form can be short without being evasive.

Salary, royalties or other remuneration paid by the investigator's own institution do not count, where the investigator is employed or appointed there. That includes intellectual property rights assigned to the institution and agreements to share in royalties from them.

Any ownership interest in the institution itself does not count, where the institution is a commercial or for-profit organisation.

Income from investment vehicles such as mutual funds and retirement accounts does not count, so long as the investigator does not directly control the investment decisions in them.

Income from seminars, lectures or teaching engagements sponsored by a government agency, an institution of higher education, an academic teaching hospital, a medical centre or an affiliated research institute does not count. Neither does income from service on advisory committees or review panels for those same bodies.

The pattern across all five is consistent. The rule is aimed at money flowing from outside entities whose commercial fortunes the research could move. It is not aimed at ordinary academic employment, ordinary retirement saving, or public-sector service.

The determination, the plan, and the part that becomes public

Disclosure comes first and on a schedule. Each investigator planning to participate must disclose no later than the time of application. Each participating investigator must submit an updated disclosure at least annually during the award period, including anything not disclosed initially and updated values for anything previously disclosed. And any new significant financial interest acquired — the rule names purchase, marriage and inheritance as examples — must be disclosed within thirty days of discovering or acquiring it.

The institution then applies a two-step test. An interest is related to the funded research when the designated official reasonably determines that it could be affected by the research, or that it is in an entity whose financial interest could be affected by the research. It is a conflict when the official reasonably determines that it could directly and significantly affect the design, conduct or reporting of the research. Related is a wider net than conflicted, and both determinations are the institution's to make.

The management plan is not a template. The rule lists seven examples of conditions or restrictions that might be imposed: public disclosure of the conflict when presenting or publishing the research; for human subjects research, disclosure directly to participants; appointment of an independent monitor capable of taking measures to protect the design, conduct and reporting against bias; modification of the research plan; change of personnel or personnel responsibilities, or disqualification of personnel from part or all of the research; reduction or elimination of the financial interest, such as sale of an equity holding; and severance of the relationships that create the conflict. Once a plan is in place, the institution must monitor compliance with it on an ongoing basis until the project is complete.

The public accessibility duty is the feature that distinguishes this regime from most others. Before spending any funds, the institution must make certain information publicly accessible — via a website, or by written response to any requester within five business days. The trigger is three conditions together: the interest was disclosed and is still held by senior or key personnel, the institution determined it is related to the funded research, and the institution determined it is a conflict.

What must be published is specified: the investigator's name; their title and role on the project; the name of the entity in which the interest is held; the nature of the interest; and its approximate dollar value. Dollar ranges are permitted, and the rule sets the bands — zero to $4,999, $5,000 to $9,999, $10,000 to $19,999, amounts between $20,000 and $100,000 in increments of $20,000, and amounts above $100,000 in increments of $50,000 — or a statement that the value cannot readily be determined. A website used for this must be updated at least annually, and within sixty days of a newly identified conflict.

When it fails: a retrospective review and a mitigation report

The rule anticipates that a conflict will sometimes be missed rather than managed, and builds a specific response.

Where a conflict is not identified or managed in a timely manner — including an investigator failing to disclose an interest that turns out to be a conflict, an institution failing to review or manage one, or an investigator failing to comply with a management plan — the institution must, within 120 days of determining the noncompliance, complete a retrospective review of the investigator's activities and the project, to determine whether any of the research conducted during the period of noncompliance was biased in its design, conduct or reporting.

That review has to be documented, and the documentation has a required contents list: project number, project title, the principal investigator, the name of the investigator with the conflict, the name of the entity the conflict is with, the reasons for the review, the detailed methodology used including the composition of the review panel and the documents reviewed, the findings, and the conclusions.

If bias is found, the institution must promptly notify the funding component and submit a mitigation report. That report must include at minimum the elements of the retrospective review plus a description of the impact of the bias on the project and the institution's plan of action — and the rule names what that description should cover, including the extent of harm done with qualitative and quantitative data supporting any actual or future harm, and an analysis of whether the research project is salvageable.

The remedies section carries the sharpest consequence. Where the department determines that a publicly funded project of clinical research whose purpose is to evaluate the safety or effectiveness of a drug, medical device or treatment has been designed, conducted or reported by an investigator with a conflict that was not managed or reported as required, the institution must require that investigator to disclose the conflict in every public presentation of the results, and to request an addendum to presentations already published. The correction follows the paper.

For a reader assessing published research, the practical point is where to look rather than what to conclude. Where this regime applies, some conflicts are on an institutional web page or available on written request within five business days, and a management plan may have required disclosure in the publication itself. Where it does not apply — privately funded work outside a covered institution — none of that machinery exists, and the absence of a public conflicts entry means nothing at all.

Sources

Each document below is named as it names itself, with the date printed on that document rather than the day it was read.

1. 42 CFR 50.601 and 50.602 — Purpose and Applicability of subpart F, read in full for the stated objective of freedom from bias in design, conduct and reporting, and for the scope tying the subpart to institutions applying for or receiving Public Health Service research funding — Electronic Code of Federal Regulations, National Archives and Records Administration, September 2026
2. 42 CFR 50.603 — Definitions, read in full for the five-thousand-dollar aggregate threshold, the any-equity rule for non-publicly traded entities, the income trigger on intellectual property, the separate travel disclosure and its exclusions, the five categories expressly excluded from significant financial interest, and the definitions of financial conflict of interest and manage — Electronic Code of Federal Regulations, National Archives and Records Administration, September 2026
3. 42 CFR 50.604 — Responsibilities of Institutions, read in full for the disclosure schedule (at application, annually, and within thirty days of a new interest), the training requirement and its four-year refresh, the two-step related-then-conflicted determination test, and the three-year records retention period — Electronic Code of Federal Regulations, National Archives and Records Administration, September 2026
4. 42 CFR 50.605 — Management and reporting of financial conflicts of interest, read in full for the requirement to manage before expenditure, the seven listed examples of management conditions, the sixty-day and 120-day clocks, the required contents of a documented retrospective review, the mitigation report contents, and the public accessibility duty with its three conditions, its five required data points and its dollar bands — Electronic Code of Federal Regulations, National Archives and Records Administration, September 2026
5. 42 CFR 50.606 — Remedies, read in full for the funding component's inquiry power before, during or after award, and for the requirement that an investigator disclose an unmanaged conflict in each public presentation of the results and request an addendum to previously published presentations — Electronic Code of Federal Regulations, National Archives and Records Administration, September 2026